Golden Valley Development, Inc. (OTC: GVDI) (www.goldenvalleydev.com) is pleased to announce the appointment of Milton Marshall PhD to its advisory board.
Dr Marshall will oversee the FDA regulatory handling for PercuguardT anti needle stick device, quality control and the near-term introduction into broad dental and medical markets, which potentially exceed one billion applications annually.
Dr. Marshall holds aPh.D. (biochemistry and virology) from the University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, followed by a postdoctoral fellowship at the University of Texas M.D. Anderson Cancer Center in Houston. Adjunct academic appointments are currently held at a dental school and a medical school. Professional certifications include toxicology (American Board of Toxicology), Registered Quality Assurance Professional - GLP (Society of Quality Assurance), and Certified Clinical Research Professional (Society of Clinical Research Associates). Career accomplishments include experience as a principal investigator, study director, laboratory director, and consultant in toxicology and regulatory compliance in new product development. Specific areas of research and development include preclinical and clinical drug, biologic, medical device, and OTC product development.
Additional information about Dr. Marshall is available at www.goldenvalleydev.com/management.
Kevin Sorrels, D.D.S., CEO of GVDI, stated, "We are excited to bring Milton onto our Board of Advisors. The design specifications require rigid quality assurance that will provide the healthcare worker with needle stick protection and yet allow for manual dexterity and tactile sensitivity. Milton brings the knowledge and experience necessary to ensure that such exacting specifications are met." Commented Dr. Marshall in accepting the position with GVDI, "This product provides a solution for accidental needle sticks in medical and dental procedures where other applications have been remiss. I look forward to joining the production team and making sure that the many qualities necessary for this product to be successful are achieved." About Golden Valley Development, Inc.
Golden Valley Development, Inc. is a publicly-traded product development and technology licensing company based in Clearwater, FL.
Through two of its wholly-owned subsidiaries, its business plan is to manufacture and market patented products in the health care and home consumer markets, beginning with its first two products, "Cut StopT" and "PercuGuard.T" For more information, please contact the company: Golden Valley Development, Inc. 611 S. Fort Harrison Ave. # 380 Clearwater, FL 33756 Investor Hotline: 850-270-8650 Email: firstname.lastname@example.org Forward-Looking Statements Portions of this press release contain forward-looking statements and involve risks and uncertainties that could materially affect expected results of operations, liquidity, cash flows and business prospects.
SOURCE Golden Valley Development, Inc.
-0- 04/24/2012 /Web Site: http://www.goldenvalleydev.com (OTC-PINK:GVDI) / CO: Golden Valley Development, Inc.
ST: Florida Texas IN: HEA MTC DEN OTC MEQ SU: PDT PER PRN -- SF93217 -- 0000 04/24/2012 07:02:00 EDT http://www.prnewswire.c